Myteka (4mg) 14 Tablets

Description

Description

Myteka (4mg) is a chewable tablet containing Montelukast Sodium, specifically formulated for young children aged 2 to 5 years to help prevent asthma symptoms and manage seasonal allergic rhinitis. Each pack contains 14 tablets, offering a two-week supply for children following a pediatrician-guided treatment plan. As the lowest strength in the Myteka range, this chewable, child-friendly tablet is designed to make daily administration easier for young patients who may not be able to swallow standard tablets. Like other Myteka formulations, it is intended for ongoing preventive care rather than emergency relief during a sudden breathing episode.

Ingredients

Each tablet of Myteka (4mg) contains a single active pharmaceutical ingredient: Montelukast Sodium 4mg, formulated as a chewable tablet with a pleasant taste suited for young children. Montelukast belongs to the leukotriene receptor antagonist class of medicines, working by targeting inflammatory pathways involved in airway constriction and allergic responses. The tablet also includes standard pediatric-friendly excipients that support flavor, texture, and consistent absorption.

Uses

Myteka (4mg) is primarily prescribed for the prevention and long-term management of mild to moderate persistent asthma in young children, helping reduce the frequency and severity of symptoms such as wheezing, coughing, shortness of breath, and chest tightness. It is also used to help relieve symptoms of seasonal allergic rhinitis, including sneezing, nasal congestion, and itchy or watery eyes, and may help prevent exercise-induced bronchoconstriction in active children. Montelukast works by blocking leukotrienes, natural substances responsible for airway inflammation, swelling, and mucus production. By interrupting this inflammatory pathway, it helps keep a young child’s airways more open over time and supports better sleep and daily activity, though it does not provide immediate relief during an active asthma attack.

Dosage Form

Myteka (4mg) is available as a chewable oral tablet, specifically designed for children aged 2 to 5 years, intended for once-daily use in the evening. The complete pack contains 14 tablets, offering a convenient two-week supply as directed by a pediatrician.

How to Use

Myteka (4mg) should be given exactly as prescribed by a pediatrician, typically once daily in the evening, with or without food. The chewable tablet should be chewed or sucked by the child rather than swallowed whole, making it easier for young patients to take. This medicine should be given consistently every day, even when asthma or allergy symptoms appear well controlled, since its protective effect depends on regular, ongoing use. Parents or caregivers should never stop this medicine or change the dose without consulting the child’s doctor first.

Side Effects

Myteka is generally well tolerated in young children, though some may experience mild side effects. Commonly reported effects include headache, stomach discomfort, nausea, and occasional flu-like symptoms. In some cases, mood-related changes such as irritability or sleep disturbances have been reported and should be discussed with a doctor if noticed. More serious but uncommon reactions may include signs of an allergic response, such as rash, swelling, or difficulty breathing, which require immediate medical attention. Parents should seek prompt medical advice if their child shows symptoms like abdominal pain, excessive thirst, or unusual restlessness after taking this medicine.

Pregnancy & Breastfeeding

This strength of Myteka is formulated exclusively for young children and is not relevant to pregnancy or breastfeeding considerations. For any related questions involving a breastfeeding mother and a child’s medication, a healthcare provider should always be consulted directly.

Storage Instructions

Store Myteka chewable tablets at room temperature, away from excess heat, light, and moisture. Keep the tablets in their original packaging until ready for use, and store them safely out of the reach of children, despite this medicine being formulated for pediatric use. Do not use tablets that have passed their printed expiry date.

FAQs

What age group is Myteka 4mg intended for?
It is specifically formulated for children aged 2 to 5 years, as advised by a doctor.

Can this medicine stop a sudden asthma attack?
No, it is intended for prevention only and is not a rescue treatment for acute symptoms; a rescue inhaler should be used for sudden attacks.

How should the chewable tablet be given?
It should be chewed or sucked by the child rather than swallowed whole.

Is daily use safe for young children?
Yes, once-daily use is considered safe for children aged 2 to 5 years when prescribed and monitored by a doctor.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.